Professor of Ophthalmology, Chief of Ophthalmic Genetics, University of California San Diego, CA, USA
Kang’s clinical and research focuses are on novel disease gene targets and treatment, gene and stem cell-based therapies in AMD, diabetic retinopathy, and inherited retinal degeneration. His laboratory uses genetic analyses to gain insights into the molecular mechanisms that underpin macular degeneration and other eye diseases; this knowledge is then used to make genetic changes that either protect the retina from damage, or actively encourage regeneration.
What are your goals for the future?
“Eliminating blindness using gene and stem cell therapy, and artificial intelligence.”
Grow your Own